Physician profile
Christopher Chen
NPI 1356704407
$13,234.38
in general payments reported to CMS, 2019-2025
38 companies · $5,018 in 2025
The $5,018 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $414 · 2021: $1,445 · 2022: $2,311 · 2023: $1,569 · 2024: $2,180 · 2025: $5,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,745 · Travel and Lodging: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,744.62 |
| Travel and Lodging | $1,023.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,594.80 | 2021-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,948.65 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,478.24 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $833.51 | 2022-2025 | |
| Abbott Laboratories | $698.82 | 2024-2025 | Ensite, Aveir, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $629.86 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $508.60 | 2020-2025 | Farxiga, Wainua |
| Amgen INC. | $363.13 | 2020-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $267.37 | 2023-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $238.58 | 2020-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $233.57 | 2023 | Optimizer, Optimizer |
| Biosense Webster, INC. | $232.57 | 2023-2025 | Carto 3 |
| Novo Nordisk INC | $205.67 | 2023-2025 | Rybelsus, Ozempic |
| Teleflex LLC | $170.13 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $158.41 | 2024 | Arcalyst |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $154.45 | 2019-2021 | |
| Pfizer INC. | $148.02 | 2022-2025 | |
| Abiomed | $135.11 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $125.93 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Baxter Healthcare | $113.55 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $102.71 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $92.89 | 2024 | |
| Lilly USA, LLC | $92.58 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $88.96 | 2024 | Verquvo |
| Heartflow, INC. | $71.86 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.36 | 2024-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $59.88 | 2024 | Assure Wcd |
| Glaxosmithkline, LLC. | $58.45 | 2025 | Shingrix |
| Biodelivery Sciences International, INC. | $50.65 | 2019 | |
| Alnylam Pharmaceuticals INC. | $50.32 | 2023-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $44.76 | 2023 | |
| Kiniksa Pharmaceuticals, Ltd. | $44.36 | 2023 | Arcalyst |
| Philips North America LLC | $43.05 | 2023-2025 | Mcot |
| Cathworks, INC. | $33.47 | 2020-2021 | |
| Ionis Pharmaceuticals, INC. | $32.41 | 2025 | Tryngolza |
| Shockwave Medical, INC | $25.01 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Coopersurgical, INC. | $16.37 | 2025 | Insorb |
| Irhythm Technologies, INC. | $16.32 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.